2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1841
Neoplasms
1230
Colorectal Neoplasms
1046
Carcinoma, Non-Small-Cell Lung
996
Stomach Neoplasms
787
Carcinoma, Hepatocellular
780
Lung Neoplasms
756
Prostatic Neoplasms
682
Pancreatic Neoplasms
567
Rectal Neoplasms
444
Colonic Neoplasms
401
Neoplasm Metastasis
400
Ovarian Neoplasms
399
Uterine Cervical Neoplasms
395
Recurrence
380
Leukemia, Myeloid, Acute
367
Esophageal Neoplasms
352
Multiple Myeloma
340
Lymphoma
330
Head and Neck Neoplasms
326
Melanoma
306
Precursor Cell Lymphoblastic Leukemia-Lymphoma
288
Brain Neoplasms
263
Urinary Bladder Neoplasms
249
Nasopharyngeal Carcinoma
221
Liver Neoplasms
221
Leukemia
217
Lymphoma, Large B-Cell, Diffuse
213
Polycystic Ovary Syndrome
206
Squamous Cell Carcinoma of Head and Neck
200
Interventions
Valsartan
1
Hydroxychloroquine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Nephritis
×
Clear all
NCT02765594
2017-09-20
HCQIgAN
Peking Union Medical College Hospital
Phase 4
Unknown
98 enrolled